Loading...
XNAS
MODD
Market cap21mUSD
Oct 08, Last price  
2.66USD
1D
0.00%
1Q
-33.33%
IPO
-80.30%
Name

Modular Medical Inc

Chart & performance

D1W1MN
XNAS:MODD chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
61.64%
Rev. gr., 5y
%
Revenues
0
Net income
-28m
L+50.03%
-6,482-6,716-9,400-7,668-9,174-17,492-20,790-22,794-30,994-31,084-106,559-659,246-2,539,498-5,320,873-7,377,976-18,632,761-13,879,000-17,470,000-18,824,000-28,242,000
CFO
-24m
L+51.10%
0-6,716000-17,492000-10,663-94,810-791,131-1,807,934-4,094,839-5,908,662-10,259,528-11,011,644-13,952,000-15,720,000-23,753,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.

Key people

Paul DiPerna
Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary · since 2017
IPO date
Jan 13, 2006
Employees
37
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT